Insmed INSM International — Product revenues, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Insmed in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Insmed’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Insmed's international — product revenues, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Insmed's international — product revenues, net?
- Insmed (INSM) reported international — product revenues, net of $35.9M in Q1 2026.
- How has Insmed's international — product revenues, net changed year-over-year?
- Insmed's international — product revenues, net increased by 25.7% year-over-year, from $28.55M to $35.9M.
- What does international — product revenues, net mean?
- This metric represents the total net sales generated from pharmaceutical products within international geographic markets after accounting for returns, rebates, and discounts. It serves as a primary indicator of the company's commercial footprint and market penetration outside of its domestic region. Tracking this figure helps investors assess the success of global product launches and the scalability of the international business model.